| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $303.4M | +20.4% |
| Cost of Revenue | $87.8M | +29.4% |
| Gross Profit | $215.6M | +17.1% |
| R&D Expense | $94.1M | +29.5% |
| SG&A Expense | $63.8M | +45.1% |
| Operating Income | $5.1M | -82.0% |
| Pre-tax Income | -$5.3M | +29.9% |
| Income Tax | $1.4M | +179.3% |
| Net Income | -$8.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $250.7M | -1.5% |
| Short-term Investments | $4.9M | — |
| Accounts Receivable | $72.6M | +44.6% |
| Current Assets | $356.3M | +10.9% |
| Total Assets | $481.9M | +40.0% |
| Current Liabilities | $66.0M | +111.6% |
| Long-term Debt | $51.6M | -5.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.0M | +1627.4% |
| Capital Expenditures | $7.8M | +54.4% |
| Investing Cash Flow | -$76.6M | -1423.4% |
| Financing Cash Flow | $16.2M | -91.7% |
| Free Cash Flow | $50.2M | +3114.2% |
| +3.0% |
| EPS (Basic) | -$0.04 | +20.0% |
| EPS (Diluted) | -$0.04 | +20.0% |
| Total Liabilities |
| $143.6M |
| +74.0% |